- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07452393
Psychological Factors and Self-Care Behaviors in Spanish Youth With Type 1 Diabetes: Age- and Sex-Based Comparisons and Associations (SPAIN-T1DM)
March 9, 2026 updated by: University of Alicante
This is a multicenter, observational, cross-sectional study of young people aged 10 to 25 with type 1 diabetes in Spain, affiliated with a diabetes association or federation.
Data will be collected through an online questionnaire in which participants voluntarily and anonymously self-report their responses.
The study aims to assess psychological factors (psychological distress, risk of eating disorders, and self-perceived health status), health care behaviors (treatment adherence, diet, and physical activity), and sociodemographic data, exploring differences by age and sex and examining associations between variables.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
115
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Alicante, Spain
- University of Alicante, Faculty of Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Young participants aged 10 to 25 years with a diagnosis of type 1 diabetes, affiliated with diabetes associations or federations in Spain.
Description
Inclusion Criteria:
- Individuals with type 1 diabetes mellitus (diagnosed).
- Affiliated with any diabetes association or federation in Spain.
- Aged between 10 and 25 years.
- Individuals who are willing to participate (for adults) or whose legal guardians provide consent (for minors).
Exclusion Criteria:
- None.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-perceived Health Status
Time Frame: Day 1
|
Self-perceived health status will be assessed using a single-item question ("How healthy do you think you are?"), rated on a 5-point Likert scale, where 1 represents "very unhealthy" and 5 represents "very healthy."
|
Day 1
|
|
Psychological Distress
Time Frame: Day 1
|
Psychological distress was assessed using the 2-item Diabetes Distress Scale (DDS2; short form of the Diabetes Distress Scale), a validated questionnaire that measures diabetes-related emotional burden and distress associated with disease management.
The scale consists of two items scored from 1 to 6.
The final score is calculated as the mean of the two item responses, resulting in a total score ranging from 1 to 6, with higher scores indicating greater diabetes-related psychological distress.
A score of ≥3 is considered indicative of clinically significant diabetes distress.
|
Day 1
|
|
Risk of Eating Disorders
Time Frame: Day 1
|
Risk of eating disorders was assessed using the Diabetes Eating Problem Survey-Revised (DEPS-R), a validated questionnaire that screens for disordered eating behaviors in individuals with type 1 diabetes.
The questionnaire consists of 16 items rated on a 5-point Likert scale (never, sometimes, often, usually, or always).
The total score is calculated by summing the item responses, resulting in a score ranging from 0 to 80, with higher scores indicating greater risk of disordered eating behaviors.
A score of ≥20 is considered indicative of risk for an eating disorder in adolescents with type 1 diabetes.
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Age
Time Frame: Day 1
|
Age will be recorded in years at the time of study participation.
|
Day 1
|
|
Gender
Time Frame: Day 1
|
Gender will be self-reported by participants as part of the sociodemographic information.
|
Day 1
|
|
Diabetes Duration
Time Frame: Day 1
|
Diabetes duration will be recorded as the number of years since the diagnosis of type 1 diabetes at the time of study participation.
|
Day 1
|
|
Weight
Time Frame: Day 1
|
Weight will be self-reported by participants in kilograms at the time of study participation.
|
Day 1
|
|
Height
Time Frame: Day 1
|
Height will be self-reported by participants in centimeters at the time of study participation.
|
Day 1
|
|
Body Mass Index (BMI)
Time Frame: Day 1
|
BMI was calculated as weight (kg) divided by height squared (m²).
|
Day 1
|
|
Treatment Adherence
Time Frame: Day 1
|
Treatment adherence was assessed using the Diabetes Management Questionnaire (DMQ), a validated instrument that evaluates adherence to prescribed diabetes care regimens.
The questionnaire consists of 20 items rated on a 5-point Likert scale.
The total score is calculated by summing the item responses, with some items reverse-scored, resulting in a total score ranging from 0 to 100, with higher scores indicating better adherence to diabetes self-management and treatment recommendations.
No established clinical cut-off values exist for adolescents with type 1 diabetes.
|
Day 1
|
|
Adherence to the Mediterranean diet
Time Frame: Day 1
|
Adherence to the Mediterranean diet was assessed using the KIDMED questionnaire, a validated instrument that evaluates dietary habits and quality in young people.
The questionnaire consists of 16 items with yes/no responses, with some items scored positively and others negatively.
The total score is calculated by summing the item responses, resulting in a total score ranging from 0 to 12. Higher scores indicate better adherence to the Mediterranean diet.
Adherence is categorized as follows: 8 points - Optimal Mediterranean diet, indicating excellent adherence; 4-7 points - Needs improvement, indicating a need to adjust dietary patterns toward the Mediterranean model; ≤3 points - Very low-quality diet, indicating poor adherence.
|
Day 1
|
|
Physical Activity
Time Frame: Day 1
|
Physical activity was assessed using the Adolescent Physical Literacy Questionnaire (APALQ), a validated instrument that measures frequency, duration, and intensity of physical activity in young people.
The questionnaire consists of 5 items rated on a Likert-type scale (never, 1-2 times a month, once a week, 2-3 times a week, and 4 or more times a week).
The total score is calculated by summing the item responses, resulting in a total score ranging from 5 to 25, with higher scores indicating greater frequency and intensity of physical activity.
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 17, 2025
Primary Completion (Actual)
August 20, 2025
Study Completion (Actual)
August 20, 2025
Study Registration Dates
First Submitted
February 27, 2026
First Submitted That Met QC Criteria
February 27, 2026
First Posted (Actual)
March 5, 2026
Study Record Updates
Last Update Posted (Actual)
March 11, 2026
Last Update Submitted That Met QC Criteria
March 9, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Endocrine System Diseases
- Mental Disorders
- Metabolic Diseases
- Signs and Symptoms, Digestive
- Autoimmune Diseases
- Immune System Diseases
- Glucose Metabolism Disorders
- Diabetes Mellitus
- Pathological Conditions, Signs and Symptoms
- Behavior
- Nutritional and Metabolic Diseases
- Signs and Symptoms
- Diabetes Mellitus, Type 1
- Feeding and Eating Disorders
- Motor Activity
Other Study ID Numbers
- UA-2024-09-27_2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychological Distress
-
Universita di VeronaUniversity of Roma La SapienzaRecruitingDistress, Emotional | Distress, PsychologicalItaly
-
Utah State UniversityCompletedPsychological Distress | Psychological Flexibility | Psychological Well-BeingUnited States
-
University of Campania "Luigi Vanvitelli"RecruitingPsychological Distress | Psychological Intervention | University StudentsItaly
-
VA Office of Research and DevelopmentNot yet recruitingPsychological DistressUnited States
-
Butler HospitalNational Center for Complementary and Integrative Health (NCCIH)Recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
VA Eastern Colorado Health Care SystemUniversity of Colorado, Denver; Military Suicide Research ConsortiumCompletedPsychological DistressUnited States
-
Medical University InnsbruckCompleted
-
Dokuz Eylul UniversityCompletedPsychological DistressTurkey
-
Gunther MeinlschmidtCompletedPsychological DistressGermany